Translumbosacral neuromodulation therapy with 2400 and 3600 magnetic pulses significantly reduces fecal incontinence episodes compared to sham, with responder rates up to 81.1%.
- Open access
- 1 cites
Moving in medRxiv, Applied and environmental microbiology, BMJ, eLife, Gastroenterology.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
Translumbosacral neuromodulation therapy with 2400 and 3600 magnetic pulses significantly reduces fecal incontinence episodes compared to sham, with responder rates up to 81.1%.
ESR1+ neurons in the pontine micturition center precisely control bladder and urethral sphincter coordination with 100% reliability in mammals.
Journals this month
Moving areas, week to 3 Oct 2026